Breaking News

Rezon Bio Launches as European CDMO for Biologics

Offers clients an end-to-end path from cell line development through GMP manufacturing and commercial supply.

Author Image

By: Charlie Sternberg

Associate Editor

Rezon Bio has launched as a European contract development and manufacturing organization (CDMO) for biologics, building on a legacy of advancing biologics from gene to global commercialization through established partners. With two facilities in Gdańsk and Warsaw-Duchnice, Rezon Bio offers clients an end-to-end path from cell line development through GMP manufacturing and commercial supply. Both sites feature mirrored capabilities, enabling seamless technology transfer and flexible scale-up. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters